Compound
A synthetic peptide agonist acting at both the glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 receptors. Its backbone is based on the GIP sequence, with a fatty acid chain promoting albumin binding.
| Format | Lyophilised powder |
|---|---|
| Purity | ≥99% |
| Appearance | White to off-white powder |
| Storage | Store at -20 °C, protected from light. Reconstituted material refrigerated. |
Research use only. Not for human consumption.